Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 7:15 PM ET


Company Overview of Intra-Cellular Therapies, Inc.

Company Overview

Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depression, and other neuropsychiatric and neurological disorders. The company also develops ITI-002 program that is in phase 1 development for the treatment of central nervous system, cardiovascular, and other disorders. Intra-Cellular Therapies, Inc. has a license and collaboration agreement with Takeda Pharmaceutical...

430 East 29th Street

New York, NY 10016

United States

25 Employees



Key Executives for Intra-Cellular Therapies, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 62
Total Annual Compensation: $954.0K
Co-Founder and Vice President of Business Development
Age: 55
Total Annual Compensation: $283.7K
Chief Financial Officer, Vice President of Finance, Treasurer and Assistant Secretary
Age: 59
Total Annual Compensation: $386.3K
Senior Vice President, General Counsel and Secretary
Age: 42
Total Annual Compensation: $207.5K
Vice President of Corporate Communications & Investor Relations
Age: 44
Total Annual Compensation: $294.4K
Compensation as of Fiscal Year 2014.

Intra-Cellular Therapies, Inc. Key Developments

Intra-Cellular Therapies, Inc. Presents at Jefferies Autumn 2015 Global Healthcare Conference, Nov-19-2015 10:40 AM

Intra-Cellular Therapies, Inc. Presents at Jefferies Autumn 2015 Global Healthcare Conference, Nov-19-2015 10:40 AM. Venue: The May Fair Hotel, Stratton Street, London, United Kingdom. Speakers: Sharon Mates, Co-Founder, Chairman, Chief Executive Officer and President.

Intra-Cellular Therapies, Inc. Presents at Boston Biotech Conferences 2015, Nov-12-2015 04:00 PM

Intra-Cellular Therapies, Inc. Presents at Boston Biotech Conferences 2015, Nov-12-2015 04:00 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States.

Intra-Cellular Therapies, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter Ended September 30, 2015

Intra-Cellular Therapies, Inc. reported unaudited consolidated earnings results for the third quarter ended September 30, 2015. For the quarter, the company reported loss from operations of $32,349,375 against $6,503,606 a year ago. Net loss was $32.2 million, or $0.91 per basic and diluted share, compared to $6.4 million or $0.22 per basic and diluted share a year ago.

Similar Private Companies By Industry

Company Name Region
BioMimetix Pharmaceutical, Inc. United States
Taylor Technology, Inc. United States
Koloseum Nutritional Sciences, Inc. United States
Rivanna Pharmaceuticals Inc. United States
Quintessence Biosciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intra-Cellular Therapies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at